Home Pfizer

Pfizer

Random

Pfizer

Pfizer, BioNTech Report 95% Final Efficacy for COVID-19 Vaccine

Pfizer

Pfizer Raises Gene Therapy Stake with $500M Sanford, NC, Expansion

Pfizer

Pfizer, BioNTech COVID-19 Vaccine >90% Effective in Early Phase III Data

Pfizer

Pfizer, Sangamo Report Positive Phase I/II Data for Severe Hemophilia A Gene Therapy

Senior male is about to receive Covid-19 coronavirus vaccine

Pfizer

COVID-19: AstraZeneca, U. of Oxford Resume Phase III Trial; Pfizer, BioNTech Eye 14,000 More Participants

Pfizer

Pfizer Raises Gene Therapy Stake with $500M Sanford, NC, Expansion

Pfizer

Pfizer, BioNTech COVID-19 Vaccine >90% Effective in Early Phase III Data

Pfizer

Pfizer, BioNTech Plan Clinical Trial for COVID-19 mRNA Vaccine Candidate

Pfizer

Pfizer, BioNTech Gain Temporary U.K. Authorization for COVID-19 Vaccine

Pfizer

Pfizer, Sangamo Report Positive Phase I/II Data for Severe Hemophilia A...

Pfizer

Pfizer to Develop Akcea/Ionis Antisense Candidate for Up to $1.5B

Pfizer

FDA Set to Authorize Emergency Use of Pfizer/BioNTech COVID-19 Vaccine

Pfizer

Sangamo CEO Ponders Pipeline, Reflects on Phase III ‘Proud Moment’

Senior male is about to receive Covid-19 coronavirus vaccine

Pfizer

COVID-19: AstraZeneca, U. of Oxford Resume Phase III Trial; Pfizer, BioNTech...

Pfizer

Quartet of COVID-19 Vaccine Candidates Head toward the Homestretch